Enveric Biosciences, Inc. (ENVB) DCF Valuation

Enveric Biosciences, Inc. (ENVB) Valoración de DCF

US | Healthcare | Biotechnology | NASDAQ
Enveric Biosciences, Inc. (ENVB) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Enveric Biosciences, Inc. (ENVB) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Simplifique la valoración de Enveric Biosciences, Inc. (ENVB) con esta calculadora DCF personalizable! Con Real Enveric Biosciences, Inc. (CELETB) financieras y entradas de pronóstico ajustables, puede probar escenarios y descubrir el valor razonable de Enveric Biosciences, Inc. (UNTB) en minutos.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 39.9 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 -100 0 0 0 -25 -25 -25 -25 -25
EBITDA -2.3 -6.3 -64.0 -19.6 -17.1 .0 .0 .0 .0 .0
EBITDA, % -5.83 100 100 100 100 78.83 78.83 78.83 78.83 78.83
Depreciation 2.3 .1 .7 .4 .0 .0 .0 .0 .0 .0
Depreciation, % 5.68 100 100 100 100 81.14 81.14 81.14 81.14 81.14
EBIT -4.6 -6.4 -64.6 -20.1 -17.1 .0 .0 .0 .0 .0
EBIT, % -11.51 100 100 100 100 77.7 77.7 77.7 77.7 77.7
Total Cash .4 1.6 17.4 17.7 2.3 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 6.4 .0 .0 .0 .2
Account Receivables, % 15.99 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 0 100 100 100 100 80 80 80 80 80
Accounts Payable 4.7 .7 .7 .5 1.2 .0 .0 .0 .0 .0
Accounts Payable, % 11.77 100 100 100 100 82.35 82.35 82.35 82.35 82.35
Capital Expenditure -.1 .0 -.9 -.6 .0 .0 .0 .0 .0 .0
Capital Expenditure, % -0.21128 100 100 100 100 -0.04225564 -0.04225564 -0.04225564 -0.04225564 -0.04225564
Tax Rate, % 99.9 99.9 99.9 99.9 99.9 99.9 99.9 99.9 99.9 99.9
EBITAT -4.9 -6.0 -56.1 -18.6 .0 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -4.4 -3.5 -56.3 -18.9 .5 -1.0 .0 .0 .0 .0
WACC, % 6.66 6.66 6.66 6.66 6.66 6.66 6.66 6.66 6.66 6.66
PV UFCF
SUM PV UFCF -.9
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -1
Net Debt -2
Equity Value 1
Diluted Shares Outstanding, MM 2
Equity Value Per Share 0.63

What You Will Get

  • Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real ENVB financials.
  • Real-World Data: Historical data and forward-looking estimates (as illustrated in the highlighted cells).
  • Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Automatic Calculations: Instantly observe how your inputs affect Enveric Biosciences’ valuation.
  • Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.

Key Features

  • Comprehensive Data: Enveric Biosciences’ historical financial reports and projected forecasts.
  • Customizable Parameters: Modify WACC, tax rates, revenue growth, and EBITDA margins to fit your analysis.
  • Real-Time Insights: Observe Enveric Biosciences’ intrinsic value update instantly.
  • Intuitive Visualizations: Dashboard graphs showcase valuation outcomes and essential metrics.
  • Designed for Precision: A robust tool tailored for analysts, investors, and finance professionals.

How It Works

  • Download: Get the pre-formatted Excel file containing Enveric Biosciences, Inc.'s (ENVB) financial data.
  • Customize: Modify projections, such as revenue growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Develop various projections and instantly compare results.
  • Make Decisions: Leverage the valuation findings to inform your investment strategy.

Why Choose Enveric Biosciences, Inc. (ENVB) Calculator?

  • Comprehensive Tool: Offers DCF, WACC, and financial ratio analyses tailored for biotech investments.
  • Customizable Inputs: Modify the highlighted fields to explore different financial scenarios.
  • Detailed Insights: Automatically computes Enveric’s intrinsic value and Net Present Value.
  • Preloaded Data: Access to historical and projected data for accurate analysis.
  • Professional Quality: Perfect for financial analysts, investors, and biotech consultants.

Who Should Use Enveric Biosciences, Inc. (ENVB)?

  • Healthcare Investors: Develop comprehensive valuation models for biotech investments.
  • Pharmaceutical Analysts: Assess valuation scenarios to inform strategic decisions in drug development.
  • Consultants and Advisors: Deliver precise valuation insights for Enveric Biosciences stock.
  • Students and Educators: Utilize real-world biotech data to enhance financial modeling skills.
  • Biotech Enthusiasts: Gain insights into how companies like Enveric Biosciences are valued in the healthcare market.

What the Template Contains

  • Pre-Filled Data: Includes Enveric Biosciences' historical financials and projections.
  • Discounted Cash Flow Model: Editable DCF valuation model with automated calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on tailored inputs.
  • Key Financial Ratios: Assess Enveric Biosciences' profitability, efficiency, and leverage.
  • Customizable Inputs: Easily modify revenue growth, margins, and tax rates.
  • Clear Dashboard: Visual representations and tables summarizing key valuation outcomes.

No products were found matching.